June 6, 2007
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts -- more

April 3, 2007
Lilly Announces Completion of Hypnion Acquisition -- more

January 26, 2007
Illumina Announces the Completion of Its Acquisition of Solexa -- more




May 2, 2008
Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454 -- more

May 1, 2008
Critical Therapeutics Signs Definitive Agreement to Merge with Cornerstone BioPharma -- more

April 30, 2008
Dynogen to Present Positive Clinical Data For DDP225 And DDP733 At Digestive -- more

April 28, 2008
Elixir Pharmaceuticals Announces Issuance of SIRT Patent Covering Development of New Therapies Based on Breakthrough Science -- more

April 21, 2008
Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis -- more

April 21, 2008
Santhera Shareholders Approve all Board Proposals at Annual Shareholders' Meeting -- more

April 17, 2008
BrainCells Inc. Expands Series B Financing to $50 Million -- more

April 16, 2008
Xanthus’ Symadex Reverses Disease in Preclinical Mouse Models of Multiple Sclerosis -- more

April 15, 2008
Pathway Medical Technologies, Inc. Secures $24.5 Million Financing -- more

April 15, 2008
Xanthus Presents Data Supporting Distinctive Mechanism of Action for Xanafide® -- more




April 11, 2008
Santhera Presents Clinical Efficacy Data of SNT-MC17 in DMD at the American Academy of Neurology Annual Meeting --
Archived News Items